CAS 178307-42-1

Revaprazan Hydrochloride

Description:

Revaprazan Hydrochloride is a novel compound classified as a potassium-competitive acid blocker (P-CAB), primarily used for the treatment of acid-related gastrointestinal disorders. It functions by selectively inhibiting the gastric H+/K+-ATPase enzyme, which plays a crucial role in gastric acid secretion. This inhibition leads to a reduction in gastric acidity, making it beneficial for conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. Revaprazan Hydrochloride is characterized by its high potency and rapid onset of action compared to traditional proton pump inhibitors (PPIs). The compound is typically administered orally and exhibits good bioavailability. Its chemical structure includes a pyridine ring, contributing to its pharmacological properties. Additionally, Revaprazan Hydrochloride has been noted for its favorable safety profile, with a lower incidence of side effects commonly associated with long-term acid suppression therapies. As research continues, its potential applications in various gastrointestinal disorders are being explored, highlighting its significance in modern therapeutic regimens.

Formula: C₂₂H₂₄ClFN₄

InChI: InChI=1/C22H23FN4.ClH/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3;/h4-11,16H,12-13H2,1-3H3,(H,24,25,26);1H

SMILES: Cc1c(C)nc(Nc2ccc(cc2)F)nc1N1CCc2ccccc2C1C.Cl

Synonyms:

• 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, monohydrochloride
• N-(4-Fluorophenyl)-5,6-dimethyl-4-((1RS)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine monohydrochloride
• Revanex
• Sb 641257A
• Unii-4Dq6T10R64
• Yh 1885
• Yh1885
• N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine hydrochloride (1:1)

Revaprazan (hydrochloride)

CAS: 178307-42-1

Formula: C₂₂H₂₄ClFN₄

Purity: 98%

Molecular weight: 398.9042

Ref: IN-DA0025XC

Revaprazan-d4 HCl

CAS: 178307-42-1

Formula: C₂₂H₁₉D₄FN₄·HCl

Molecular weight: 366.48 36.46

Ref: 4Z-R-083002

Revaprazan HCl

CAS: 178307-42-1

Formula: C₂₂H₂₃FN₄·HCl

Color and Shape: White To Off-White Solid

Molecular weight: 362.45 36.46

Ref: 4Z-R-083001

Revaprazan hydrochloride

CAS: 178307-42-1

Revaprazan hydrochloride

Purity: ≥98%

Molecular weight: 398.9g/mol

Ref: 54-BUP17000

Revaprazan hydrochloride

CAS: 178307-42-1

Formula: C₂₂H₂₄ClFN₄

Molecular weight: 398.90

Ref: 7W-GP3133

Revaprazan hydrochloride

CAS: 178307-42-1

Revaprazan hydrochloride (YH1885) is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity.

Formula: C₂₂H₂₄ClFN₄

Purity: 99.62% - 99.91%

Color and Shape: Solid

Molecular weight: 398.9

Ref: TM-T2405

Revaprazan hydrochloride

CAS: 178307-42-1

K+/H+ ATPase inhibitor

Formula: C₂₂H₂₃FN₄•HCl

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 398.9 g/mol

Ref: 3D-FR27722

Revaprazan HCl - Bio-X ™

CAS: 178307-42-1

Revaprazan is a proton pump inhibitor drug that is used for the treatment of GERD and other conditions related to an excess in stomach acid production. This drug works by inhibiting the proton pump in the stomach lining known as the H+/K+-ATPase, resulting in a reduction of stomach acid and relief of symptoms.

Formula: C₂₂H₂₄ClFN₄

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 398.9 g/mol

Ref: 3D-BR164337

Revaprazan Hydrochloride

Controlled Product

CAS: 178307-42-1

Formula: C₂₂H₂₃FN₄·ClH

Color and Shape: Neat

Molecular weight: 398.904

Ref: TR-R279500